The BCL-2 gene family

Seminars in Cancer Biology

Volumn 6, Issue 1, 1995, Pages 35-43

  Craig, Ruth W ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

bax; bcl x; bd 2; ced9; mcl 1

Indexed keywords

ONCOPROTEIN; PROTO ONCOGENE PROTEINS; PROTO ONCOGENE PROTEINS C BCL 2;

AMINO ACID SEQUENCE; ANIMAL; EXPERIMENTAL NEOPLASM; GENETICS; HUMAN; MOLECULAR GENETICS; NEOPLASM; NEWBORN; REVIEW; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANIMAL; HUMAN; INFANT, NEWBORN; MOLECULAR SEQUENCE DATA; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SEQUENCE HOMOLOGY, AMINO ACID; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0029245192     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.1995.0005     Document Type: Article

References (71)

1. Tsujimoto Y, Croce CM (1986) Analysis of the structure, transcripts, and protein products of bcl, the gene involved in human follicular lymphoma. Proc Natl Acad Sci 83:5214-5218
2. Cleary ML, Smith SD, Sklar J (1986) Cloning and structural analysis of cDNA for bcl-2 and a hybrid bcl-2/ immunoglobulin transcript resulting from the t(14;18) translocation. Cell 47:19-28
3. Chen-Levy Z, Nourse J, Cleary ML (1989) The bcl-2 candidate proto-oncogene is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation. Mol Cell Biol 9:701-710
4. Hockenbery DM (1992) The bcl-2 oncogene and apoptosis. Semin, Immunol 4:413-420
5. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB (1993). bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597-608
6. Oltvai ZN, Milliman CL, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programed cell death. Cell 74:609-619
7. Kozopas KM, Yang T, Buchan HL, Zhou P, Craig RW (1993) MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL-2. Proc Natl Acad Sci USA 90:3516-3520
8. Lin EY, Orlofsky A, Berger MS, Prystowsky MB (1993) Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2. J Immunol 151:1979-1988
9. Hengartner MO, Ellis RE, Horvitz HR (1992) Caenorhabditis gene ced9 protects cells from programmed cell death. Nature 356:496-499
10. Pearson GR, Luka J, Petti L, Sample J, Birkenback M, Braun D, Kieff E (1987) Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex. Virology 160:151-161
11. Neilan JG, Lu Z, Afonso CL, Kutish GF, Sussman MD, Rock DL (1993) An African Swine fever virus with similarity to the proto-oncogene bcl-2 and the Epstein-Barr virus gene BHRF1. J Virol 67:4391-4394
12. Craig RW (1992) Tumor suppressor genes, the cell cycle, and cancer. J Natl Cancer Inst 84:1869-1830
13. Hockenbery D, Nunez G, Minniman C, Schreiber RD, Korsmeyer SJ (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334-336
14. Vaux DL, Cory S, Adams JM (1988) Bcl-2 gene promotes hemopoietic cell survival and cooperates with c-myc to immortalize Pre-B cells. Nature 335:440-442
15. Garcia I, Martinou I, Tsujimoto Y, Martinou JC (1992) Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science 258:302-304
16. Miyashita T, Reed JC (1993) Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 81:151-157
17. Kamesaki S, Kamesaki H, Jorgensen TJ, Tanizawa A, Pommier Y, Cossman J (1993) bcl-2 protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase II-induced DNA strand breaks and their repair. Cancer Res 53:4251-4256
18. Walton MI, Whysong D, O'Connor PM, Hockenbery D, Korsmeyer SJ, Kohn KW (1993) Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis. Cancer Res 53:1853-1861
19. Bissonnette RP, Echeverri F, Mahboubi A, Green DR (1992) Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359:552-554
20. Fanidi A, Harrington EA, Evan GI (1992) Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 359:554-556
21. Nunez G, London L, Hockenbery D, Alexander M, McKearn JP, Korsmeyer SJ (1991) Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 144:3602-3610
22. Vaux DL, Aguila HL, Weissman IL (1992) Bcl-2 prevents death of factor-deprived cells but fails to prevent apoptosis in targets of cell mediated killing. Int Immunol 4:821-824
23. Itoh N, Tsjuimoto Y, Nagata S (1993) Effect of bcl-2 on Fas antigen-mediated cell death. J Immunol 151:621-627
24. Henderson S, Huen D, Rowe M, Dawson C, Johnson G, Rickinson A (1993) Epstein-Barr virus-encoded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc Natl Acad Sci USA 90:8479-8483
25. Reynolds JE, Jenkinson JD, Zhou P, Zhou LP, Eastman, A, Craig RW (1994) Mcl-1, a member of the bcl-2 gene family, delays apoptosis induced by c-myc overexpression in CH0 cells. Cancer Res 54: 6348-6352
26. Hengartner MO, Horvitz HR (1994) C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell 76:665-676
27. Hengartner MO, Horvitz HR (1994) Activation of C. elegans cell death protein CED-9 by an amino-acid substitution in a domain conserved in bcl-2. Nature 369:318-320
28. de Jong D, Prins FA, Mason DY, Reed JC, van Ommen, GB, Kluin PM (1994) Subcellular localization of the bcl-2 protein in malignant and normal lymphoid cells. Cancer Res 54:256-260
29. Fernandez-Sarabia MJ, Bischoff JR (1993) Bcl-2 associates with the ras-related protein R-ras p23. Nature 366:274-275
30. Hengartner MO, Ellis RE, Horvitz HR (1992). Caenorhabditis gene ced9 protects cells from programmed cell death. Nature 356:494-499
31. Vaux DL, Haecker G, Strasser A (1994) An evolutionary perspective on apoptosis. Cell 76:777-779
32. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR (1993) The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 75:641-652
33. Thornberry NA, Bull HG, Calaycay JR, Chapman K, Howard A, Kostura M, Miller D, Molineaux SM, Weidner JR, Aunins J (1992) A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356:768-774
34. McCarthy NJ, Smith CA, Williams GT (1992) Apoptosis in the development of the immune system: growth factors, clonal selection and bcl-2. Cancer Metast Rev 11:157-178
35. Hockenbery DM, Zutter M, Hickery W, Nahm M, Korsmeyer SJ (1991) BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 88:6961-6965
36. Gratiot-Deans J, Ding L, Turka LA, Nunez G (1993) bcl-2 proto-oncogene expression during human T cell development. Evidence for biphasic regulation. J Immunol 151:83-91
37. Veis DJ, Sentman CL, Bach EA, Korsmeyer SJ (1993) Expression of the Bcl-2 protein in murine and human thymocytes and in peripheral T lymphocytes. J Immunol 151:2546-2554
38. Moore NC, Anderson G, Williams GT, Owen JJT, Jenkinson EJ (1994) Developmental regulation of bcl-2 expression in the thymus. Immunology 81:115-119
39. McDonnell TJ, Deane N, Platt FM, Nunez G, Jaeger U, McKearn JP, Korsmeyer SJ (1989) bcl-2-Immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 57:79-88
40. McDonnell TJ, Nunez G, Platt FM, Hockenberry D, London L, McKearn JP, Korsmeyer SJ (1990) Deregulated bcl-2-immunoglobulin transgene expands a resting but responsive immunoglobulin M and D-expressing B-cell population. Mol Cell Biol 10:1901-1907
41. Strasser A, Whittingham S, Vaux DL, Bath ML, Adams JM, Cory S, Harris AW (1991) Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci USA 88:8661-8665
42. Nunez G, Hockenbery D, McDonnell TJ, Sorensen CM, Korsmeyer SJ (1991) Bcl-2 maintains B cell memory. Nature 353:71-73
43. Strasser A, Harris AW, Cory S (1991) bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67:889-899
44. Sentman CL, Shutter JR, Hockenbery D, Kanagawa O, Korsmeyer SJ (1991) bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67:879-888
45. Siegel RM, Katsumata M, Miyashita T, Louie DC, Green MI, Reed JC (1992) Inhibition of thymocyte apoptosis and negative antigenic selection in bcl-2 transgenic mice. Proc Natl Acad Sci USA 89:7003-7007
46. Tao W, Soo-Jet T, Melhado I, Jirik F, Korsmeyer SJ, Teh H-S (1994) The T cell receptor repertoire of CD4-8+ thymocytes is altered by overexpression of the bcl-2 protooncogene in the thymus. J Exp Med 179:145-153
47. Nakayama K-I, Kakayama K, Negishi I, Kuida K, Shinkai X Louie MC, Fields LE, Lucas PJ, Stewart V, Alt FW, Loh DY (1993) Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice. Science 261:1584-1588
48. Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ (1993) Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75:229-240
49. Cuende E, Ales-Martinez JE, Ding L, Gonzalez-Garcia M, Martinez C, Nunez G (1993) Programmed cell death by bcl-2-dependent and independent mechanisms in B lymphoma cells. EMBO J 12:1555-1560
50. Allsopp TE, Wyatt S, Paterson HF, Davies AM (1993) The protooncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell 73:295-307
51. McDonnell TJ, Korsmeyer SJ (1991) Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18). Nature 349:254-256
52. Strasser A, Harris AW, Bath ML, Cory S (1990) Novel primitive lymphoid tumors induced in transgenic mice by cooperation between bcl-2 and myc. Nature 348:331-333
53. Yin X-M, Oltvai Z, Korsmeyer, SJ (1994) BH1 and BH2 domains of bcl-2 are required for inhibition of apoptosis and heterodimerization with bax. Nature 369:321-323
54. Vaux DL, Weissman IL, Kim SK (1992a) Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2. Science 258:1955-1957
55. Chen-Levy Z, Cleary ML (1990) Membrane topology of the Bcl-2 proto-oncogenic protein demonstrated in vitro. J Biol Chem 265:4929-4933
56. Krajewski K, Tanaka S, Takayama S, Schibler MJ, Fenton W, Reed JC (1993) Investigation of the subcellular distribution of the bcl-2 oncoprotein: Residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Research 53:4701-4714
57. Monaghan P, Robertson D, Andrew T, Amos S, Dyer MJS, Mason DY, Greaves MF (1992) Ultrastructural localization of BCL-2 protein. J. Histochem Cytochem 40:1819-1825
58. Nakai M, Takeda A, Cleary ML, Endo T (1993) The bcl-2 protein is inserted into the outer membrane but not into the inner membrane of rat liver mitochondria in vitro. Biochem Biophys Res Commun 196:233-239
59. Nguyen M, Millar DG, Yong VW, Korsmeyer SJ, Shore GC (1993) Targeting of Bcl-2 to the mitochondrial outer membrane by a COOH-terminal signal anchor sequence. J Biol Chem 268:25265-25268
60. Hockenbery DM, Oltvai ZN, Yin X-M, Milliman CL, Korsmeyer SJ (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241-251
61. Tanaka S, Saito K, Reed JC (1993) Structure-function analysis of the bcl-2 oncoprotein. J Biol Chem 268:10920-10926
62. Jacobson MD, Burne JF, King MP, Miyashita T, Reed JC, Raff MC (1993) Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 361:365-369
63. Meikrantz W, Gisselbrecht S, Sun WT, and Schlegel R (1994) Activation of cyclin A-dependent protein kinases during apoptosis. Proc Natl Acad Sci USA 91:3754-3758
64. Jacobson MD, Burne JF, Raff M (1994) Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J 13:1899-1910
65. Baker KP, Schatz G (1991) Mitochondrial proteins essential for viability mediate protein import into yeast mitochondria. Nature 349:205-208
66. Caron-Leslie LM, Schwartzman RA, Gaido ML, Compton MM, Cidlowski JA (1991) Identification and characterization of glucocorticoid-regulated nuclease(s) in lymphoid cells undergoing apoptosis. J Steroid Biochem Mol Biol 40:661-667
67. Baffy G, Miyashita T, Williamson JR, Reed JC (1993) Apoptosis induced by withdrawal of interleukin-3 (IL-3) from an IL-3-dependent hematopoietic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced bcl-2 oncoprotein production. J Biol Chem 268:6511-6519
68. Zhong LT, Sarafian T, Kane DJ, Charles AC, Mah SP, Edwards RH, Bredesen DE (1993) bcl-2 inhibits death of central neural cells induced by multiple agents. Proc Natl Acad Sci USA 90:4533-4537
69. Kane DJ, Sarafian TA, Anton R, Hahn H, Gralla EB, Valentine JS, Ord T, Bredesen DE (1993) Bcl-2 inhibition of neural death decreased generation of reactive oxygen species. Science 262:1274-1277
70. Williams GT, Smith CA (1993) Molecular regulation of apoptosis genetic controls on cell death. Cell 74:777-779
71. Yang T, Kozopas KM, Craig RW (1995) The intracellular distribution and pattern of expression of Mcl-1 overlap with, but are not identical to, those of Bcl-2. J Cell Biol 128, in press